| Literature DB >> 35326944 |
Víctor Manuel Mendoza-Núñez1, Gabriela Pulido-Castillo2, Elsa Correa-Muñoz1,2, Juana Rosado-Pérez1.
Abstract
BACKGROUND: Metabolic syndrome (MS) is highly prevalent in older adults; it constitutes a risk factor for cognitive deterioration, frailty, and Alzheimer's disease. For this reason, the WHO has pointed out the importance of the implementation of community programs for the training of healthy aging. The aim of this study was to evaluate the effect of a community gerontology program framed in active aging on the control of metabolic syndrome in older adults.Entities:
Keywords: community gerontology model; healthy aging; metabolic syndrome; older adults
Year: 2022 PMID: 35326944 PMCID: PMC8950718 DOI: 10.3390/healthcare10030466
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1General diagram of the study.
Figure 2Characteristics of the community gerontology program (CGP). The key element of the CGP is the formation and optimal use of social support networks with the purpose of integrating a gerontological social capital, to develop community gerontology programs, establishing as pillars the promotion of health, empowerment, autonomy, citizenship, and social recognition to adopt self-care for healthy aging through the adoption and strengthening of healthy lifestyles, to maintain, prolong, or recover physical, psychological, and social functioning, within the framework of the organization and monitoring of a “network of social support networks for healthy aging”.
Topics of the community gerontology program for healthy aging.
| Topic | Activity | Sessions per Week | Hours per Session | Total Sessions | Total Hours | |
|---|---|---|---|---|---|---|
| 1 | Active and healthy aging | Theoretical/debate | 1 | 2 | 3 | 6 |
| 2 | Healthy eating | Theoretical/practical | 1 | 2 | 3 | 6 |
| 3 | Safe physical exercise | Theoretical/practical | 1 | 2 | 3 | 6 |
| 4 | Personal and environmental hygiene | Theoretical/practical | 1 | 2 | 2 | 4 |
| 5 | Sleep hygiene | Theoretical/debate | 1 | 2 | 2 | 4 |
| 6 | Self-esteem vs. ageism | Theoretical/debate | 1 | 2 | 2 | 4 |
| 7 | Leisure and recreation | Theoretical/practical | 1 | 2 | 2 | 4 |
| 8 | Self-care for healthy aging | Theoretical/practical | 1 | 2 | 3 | 6 |
| 20 | 40 |
Sociodemographic characteristics by study group.
|
|
| |
|---|---|---|
| Age (mean ± SD) | 71 ± 9 | 69 ± 8 |
| Sex (%) | ||
| Men | 10 (33) | 8 (22) |
| Women | 20 (67) | 28 (78) |
| Civil status (%) | ||
| With couple | 9 (30) | 12 (33) |
| Without couple | 21 (70) | 24 (67) |
| Scholarship (years) | 7 ± 3 | 6 ± 3 |
| Socioeconomic level (%) | ||
| Low | 19 (63) | 25 (70) |
| Medium | 7 (23) | 8 (22) |
| High | 4 (14) | 3 (8) |
Chi-squared and Student’s t-tests; p > 0.05.
Figure 3Percentage of the number of MS criteria pre and post-intervention. In (A) (control group) pre-intervention, 28/30 (94%) subjects had 3 MS criteria, 1/30 (3%) had 4 MS criteria, and 1/30 (3%) had 5 MS criteria; post-intervention, 5/30 subjects (17%) changed from 3 to 2 MS criteria, 28/30 (94%) changed to 9/30 (30%) with 3 MS criteria, 1/30 (3%) changed to 12/30 (40%) with 4 MS criteria and 1/30 (3%) changed to 4/30 (13%) with 5 MS criteria. In (B) (experimental group), pre-intervention 28/36 (78%) subjects had 3 MS criteria, 7/36 (19%) had 4 MS criteria, and 1/36 (3%) had 5 MS criteria; post-intervention, 2/36 subjects (6%) changed from 3 to 0 MS criteria, 12/36 (33%) changed from 3 to 1 MS criteria, 12/36 (33%) changed from 3 to 2 MS criteria, 28/36 (78%) changed to 6/36 (16%) 3 MS criteria, 7/36 (19%) changed to 2/36 (6%) with 4 MS criteria, and 1/36 (3%) changed to 2/36 (6%) with 5 MS criteria. Therefore, 25/30 (83%) of the control group, in comparison with 10/36 (28%) of the experimental group, maintained a diagnosis of MS (3 or more components) after the intervention, whose difference was statistically significant (p < 0.001); (A) control group; (B) experimental group.
Mean numbers of MS diagnostic criteria pre- and post-intervention.
| Measurement | Control Group | Experimental Group | |
|---|---|---|---|
| Pre-intervention | 3.1 ± 0.4 | 3.2 ± 0.5 | |
| Post-intervention | 3.5 ± 0.9 | 2.0 ± 1.2 | <0.001 |
Data presented are means and standard deviation. Repeated measures ANOVA, 95% significance.
Pre- and post-intervention clinical parameters by group.
| Control Group | Experimental Group | ||
|---|---|---|---|
| Weight (kg) | |||
| Pre-intervention | 68 ± 12 | 71 ± 20 | |
| Post-intervention | 71 ± 10 | 66 ± 11 | 0.792 |
| Height (cm) | |||
| Pre-intervention | 158 ± 11 | 148 ± 8 | |
| Post-intervention | 157 ± 10 | 148 ± 7 | 0.997 |
| BMI (weight/height2) | |||
| Pre-intervention | 28 ± 5 | 32 ± 6 | |
| Post-intervention | 29 ± 3 | 30 ± 5 | 0.009 |
| Waist (cm) | |||
| Pre-intervention | 99 ± 10 | 104 ± 12 | |
| Post-intervention | 98 ± 9 | 102 ± 15 | 0.142 |
| Hip (cm) | |||
| Pre-intervention | 103 ± 10 | 108 ± 14 | |
| Post-intervention | 104 ± 10 | 105 ± 13 | 0.190 |
| SBP (mm Hg) | |||
| Pre-intervention | 128 ± 16 | 129 ± 14 | |
| Post-intervention | 132 ± 10 | 126 ± 20 | 0.047 |
| DBP (mm Hg) | |||
| Pre-intervention | 82 ± 8 | 85 ± 11 | |
| Post-intervention | 85 ± 9 | 81 ± 13 | 0.048 |
Abbreviations: BMI, Body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. Data presented are means and standard deviation. Repeated measures ANOVA, 95% significance.
Pre and post-intervention biochemical parameters by group.
| Control Group | Experimental Group | ||
|---|---|---|---|
| Glucose (mg/dL) | |||
| Pre-intervention | 118 ± 31 | 111 ± 20 | |
| Post-intervention | 124 ± 45 | 112 ± 32 | 0.164 |
| Urea (mg/dL) | |||
| Pre-intervention | 35 ± 7 | 35 ± 9 | |
| Post-intervention | 33 ± 8 | 37 ± 10 | 0.246 |
| Urate (mg/dL) | |||
| Pre-intervention | 5 ± 1 | 5 ± 2 | |
| Post-intervention | 6 ± 2 | 4 ± 1 | 0.080 |
| Cholesterol (mg/dL) | |||
| Pre-intervention | 206 ± 57 | 207 ± 44 | |
| Post-intervention | 211 ± 38 | 185 ± 19 | 0.140 |
| HDL (mg/dL) | |||
| Pre-intervention | 52 ± 12 | 56 ± 16 | |
| Post-intervention | 46 ± 9 | 63 ± 17 | 0.001 |
| Triglycerides (mg/dL) | |||
| Pre-intervention | 192 ± 78 | 177 ± 61 | |
| Post-intervention | 200 ± 90 | 139 ± 43 | 0.004 |
| Albumin (mg/dL) | |||
| Pre-intervention | 4.5 ± 0.23 | 4.5 ± 0.52 | |
| Post-intervention | 4.3 ± 0.51 | 4.3 ± 0.52 | 0.835 |
| Creatinine (mg/dL) | |||
| Pre-intervention | 0.91 ± 0.48 | 0.78 ± 0.20 | |
| Post-intervention | 0.78 ± 0.25 | 0.76 ± 0.32 | 0.207 |
| CRP (mg/dL) | |||
| Pre-intervention | 0.28 ± 0.39 | 0.47 ± 0.38 | |
| Post-intervention | 0.30 ± 0.47 | 0.41 ± 0.31 | 0.057 |
Abbreviations: HDL, high-density lipoprotein; CRP, C-reactive protein. Data presented are means and standard deviation. Repeated-measures ANOVA, 95% significance.
Frequency of metabolic syndrome criteria pre- and post-intervention by group.
| MS Criteria | Control Group | Difference | Experimental Group | Difference | |
|---|---|---|---|---|---|
| Abdominal circumference * | (5) | (−9) | |||
| Pre-intervention | 23 (78) | 33 (92) | |||
| Post-intervention | 25 (83) | 29 (81) | 0.125 | ||
| Glucose ≥ 110 mg/dL | (0) | (−9) | |||
| Pre-intervention | 17 (57) | 19 (53) | |||
| Post-intervention | 17 (57) | 15 (42) | 0.267 | ||
| SBP ≥ 130 mm Hg | (13) | (−33) | |||
| Pre-intervention | 14 (47) | 22 (61) | |||
| Post-intervention | 18 (60) | 10 (28) | 0.004 | ||
| DBP ≥ 85 mm Hg | (7) | (−34) | |||
| Pre-intervention | 18 (60) | 20 (56) | |||
| Post-intervention | 20 (67) | 8 (22) | 0.006 | ||
| Triglycerides ≥ 150 mg/dL | (−7) | (−11) | |||
| Pre-intervention | 26 (87) | 27 (75) | |||
| Post-intervention | 24 (80) | 13 (64) | 0.002 | ||
| HDL * | (27) | (−27) | |||
| Pre-intervention | 13 (43) | 16 (44) | |||
| Post-intervention | 21 (70) | 6 (17) | 0.031 |
Abbreviations: MS, metabolic syndrome; SBP, systolic blood pressure; DBP, diastolic blood pressure. Abdominal circumference: * Men ≥ 102 cm, Women ≥ 88 cm, HDL, * high-density lipoprotein: men ≤ 40 mg/dL, women ≤ 50 mg/dL. Data presented are frequencies and percentages. McNemar test for related samples, 95% significance.